AzTrials
AzTrials

HysterectomyNCT02621710

Goal Achievement and Patient Satisfaction in Benign Hysterectomy

An observational study of Hysterectomy and Goal Achievement, run by University Hospitals Cleveland Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates patient goal achievement and satisfaction in benign hysterectomy. Patient's will state their goals prior to undergoing benign hysterectomy, and will receive a follow-up questionnaire 3 months post-operatively evaluating their perception of goal achievement and overall satisfaction. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Questionnaire 3 months post-operatively
How many people
57 participants
Where
1 siteUnited States
Study dates
Dec 2015to 1 Mar 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients undergoing benign hysterectomy for benign indications in a scheduled manner

Who may be able to join

  • Patient undergoing hysterectomy for benign indication
  • Age 18 or greater
  • English speaking
  • Access to communication via telephone

Who cannot join

  • Patient undergoing hysterectomy for malignant or pre-malignant condition
  • Non-english speaking patient
  • Patient without telephone access
  • Patient undergoing emergent or unplanned hysterectomy
  • Vulnerable populations

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University Hospitals

    Cleveland, Ohio, 44106

Other trials in United States

About this study

This study evaluates patient goal achievement and satisfaction in benign hysterectomy. Patient's will state their goals prior to undergoing benign hysterectomy, and will receive a follow-up questionnaire 3 months post-operatively evaluating their perception of goal achievement and overall satisfaction. Goal achievement and satisfaction will be evaluated for association with surgical indication, surgical approach (minimally invasive vs abdominal surgery), and demographic information.

Being tested
Questionnaire 3 months post-operatively
Medical subject headings
Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire 3 months post-operativelyOther

Study groups in NCT02621710
Study groupRoleWhat they receive
Minimally invasive hysterectomyPatients undergoing scheduled minimally invasive hysterectomy (vaginal, laparoscopic, robotic) for benign condition
Receives: Other: Questionnaire 3 months post-operatively
Abdominal hysterectomyPatients undergoing scheduled abdominal hysterectomy for benign condition
Receives: Other: Questionnaire 3 months post-operatively

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Goal achievement score of 4 or 5

    Patients will state their goals prior to surgery, then at the three months post-operatively will rank if their goals were met on a 1-5 likert scale (1=strongly disagree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree). Goals are considered achieved with a likert score of 4 or 5.

    Measured: 3 months post-operatively

Secondary outcomes (1)
  1. Percent of patient satisfaction

    At three months post-operatively, patients will state how satisfied they are with their hysterectomy experience, from 0 to 100%.

    Measured: 3 months post-operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2015 (estimated)
  2. Study startDec 2015
  3. Primary completion1 Mar 2017
  4. Study completion1 Mar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
57 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02621710
Sponsor's protocol ID
053161
Status last verified
Oct 2017
First submitted
28 Nov 2015
Last updated
31 Oct 2017
Results posted
No

Publications

  • Pilzek AL, Raker CA, Sung VW. Are patients' personal goals achieved after pelvic reconstructive surgery? Int Urogynecol J. 2014 Mar;25(3):347-50. doi: 10.1007/s00192-013-2222-8. Epub 2013 Sep 18.

    PubMed 24045936
  • Mamik MM, Rogers RG, Qualls CR, Komesu YM. Goal attainment after treatment in patients with symptomatic pelvic organ prolapse. Am J Obstet Gynecol. 2013 Nov;209(5):488.e1-5. doi: 10.1016/j.ajog.2013.06.011. Epub 2013 Jun 13.

    PubMed 23770473
  • Hullfish KL, Bovbjerg VE, Gibson J, Steers WD. Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol. 2002 Jul;187(1):88-92. doi: 10.1067/mob.2002.124838.

    PubMed 12114893
  • Elkadry EA, Kenton KS, FitzGerald MP, Shott S, Brubaker L. Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol. 2003 Dec;189(6):1551-7; discussion 1557-8. doi: 10.1016/s0002-9378(03)00932-3.

    PubMed 14710061
  • Mahajan ST, Elkadry EA, Kenton KS, Shott S, Brubaker L. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol. 2006 Mar;194(3):722-8. doi: 10.1016/j.ajog.2005.08.043.

    PubMed 16522404
  • Nieboer TE, Johnson N, Lethaby A, Tavender E, Curr E, Garry R, van Voorst S, Mol BW, Kluivers KB. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD003677. doi: 10.1002/14651858.CD003677.pub4.

    PubMed 19588344
  • ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2009 Nov;114(5):1156-1158. doi: 10.1097/AOG.0b013e3181c33c72.

    PubMed 20168127
  • Martino MA, Berger EA, McFetridge JT, Shubella J, Gosciniak G, Wejkszner T, Kainz GF, Patriarco J, Thomas MB, Boulay R. A comparison of quality outcome measures in patients having a hysterectomy for benign disease: robotic vs. non-robotic approaches. J Minim Invasive Gynecol. 2014 May-Jun;21(3):389-93. doi: 10.1016/j.jmig.2013.10.008. Epub 2013 Oct 26.

    PubMed 24513969
  • Warren L, Ladapo JA, Borah BJ, Gunnarsson CL. Open abdominal versus laparoscopic and vaginal hysterectomy: analysis of a large United States payer measuring quality and cost of care. J Minim Invasive Gynecol. 2009 Sep-Oct;16(5):581-8. doi: 10.1016/j.jmig.2009.06.018.

    PubMed 19835801
  • Wright KN, Jonsdottir GM, Jorgensen S, Shah N, Einarsson JI. Costs and outcomes of abdominal, vaginal, laparoscopic and robotic hysterectomies. JSLS. 2012 Oct-Dec;16(4):519-24. doi: 10.4293/108680812X13462882736736.

    PubMed 23484557
  • Pitter MC, Simmonds C, Seshadri-Kreaden U, Hubert HB. The impact of different surgical modalities for hysterectomy on satisfaction and patient reported outcomes. Interact J Med Res. 2014 Jul 17;3(3):e11. doi: 10.2196/ijmr.3160.

    PubMed 25048103

Questions about this trial

What is this clinical trial studying?

An observational study of Hysterectomy and Goal Achievement, run by University Hospitals Cleveland Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Goal achievement score of 4 or 5 (time frame: 3 months post-operatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02621710, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in